Hipcricket, Inc. HIPP Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Hipcricket, Inc. HIPP Company Overview 

Stock Message Board http://investorshangout.com/search?q=HIPP&...mp;yt1=Go!

Hipcricket, Inc. HIPP Current Price and Quotes
Last Price 0.485
Previous Close 0.49 Open 0.4988
Daily Range 0.50 - 0.48 52wk Range 1.30 - 0.26
Volume 292,282 Dividend N/A
Average Vol (3m) 358,810 Yield N/A
Hipcricket, Inc. HIPP
Company Information

4400 Carillon Point
Kirkland, WA 98033
Australia

Website: http://www.augme.com
Phone: 855-423-5433

Hipcricket, Inc. HIPP
Augme Technologies, Inc. is the technology and services leader in new media marketing platforms that enable the seamless integration of brands, music, video and other content with life through the power of the Internet and mobile communications. Augme’s intuitive new media marketing platforms give companies the control they need to quickly create, deploy and measure rich-media, interactive marketing campaigns across all networks and devices. Augme marketing platforms condense the customer loyal...



Hipcricket, Inc. HIPP
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report May 31, 2013 10-Q
CIK 0001137204
Fiscal Year End 2/28
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 3669 - Communications equipment, misc
Incorporated In: DE, USA
Year of Inc. 1999
Employees 38 a/o Mar 01, 2006
Company Officers/Contacts

Ivan Braiker President, CEO
Douglas Stovall COO
Thomas Virgin CFO
Sean D. Bradley CTO
Stephanie Prince IR
James Carbonara IR
Company Directors

Dan Stout
Dennis Webb
Company Notes

Formerly=Augme Technologies, Inc. until 8-2013
Formerly=Modavox, Inc. until 3-2010
Formerly=InnerSpace Corp. until 6-03
Formerly=SurfNet Media Group, Inc. until 9-05
Service Providers

Auditor/Accountant
Moss Adams LLP
10960 Wilshire Blvd
Suite 1100
Los Angeles, CA, 90024
United States

Legal Counsel
Not Available
Investor Relations Firm
Lippert/Heilshorn & Associates
800 Third Avenue
New York, NY, 10022
United States


Hipcricket, Inc. HIPP
HIPP Security Details

Share Structure

Market Value1 $63,140,092 a/o Sep 13, 2013
Shares Outstanding 130,185,756 a/o Jul 03, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.0001
Shareholders

Shareholders of Record 475 a/o May 24, 2013
Security Notes

Capital Change=shs decreased by 1 for 10 split. Pay date=06/06/2003.
Short Selling Data

Short Interest 956,801 (0.32%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Interwest Transfer Co., Inc.

Hipcricket, Inc. HIPP Recent News

Sept 4, 2013 Hipcricket Named Finalist for 2013 Mobile Excellence Award in Mobile Social Awareness Category
Aug 23, 2013 Augme Technologies, Inc. Changes Name to Hipcricket, Inc. and Trades Under New Symbol
Aug 11, 2013 OTC Daily Alert Stock Watch - Augme Technologies, Inc. (OTCQB: AUGT)
Jul 30, 2013 Augme Announces Results of 2013 Annual Shareholders Meeting
Jul 11, 2013 Augme Technologies, Inc. Reports Fiscal First Quarter Results
Jul 4, 2013 Augme Technologies Announces Fiscal First Quarter 2014 Earnings Conference Call
Jun 27, 2013 Augme Technologies Announces 2013 Annual Meeting of Stockholders
Jun 25, 2013 Hipcricket Expands Sales Leadership Team
Jun 20, 2013 Augme Technologies Names Michael Brochu to Its Board of Directors
Jun 18, 2013 Augme Technologies Announces Promotion of Key Executive


Hipcricket, Inc. HIPP Financials
Period Ending Feb 28, 2013 Feb 29, 2012 Feb 28, 2011 Feb 28, 2010
Total Revenue 26,210 11,950 2,821 340
Cost of Revenue 10,371 4,151 1,251 493
Gross Profit 15,839 7,800 1,570 (153)
Operating Expenses

Research and Development 7,475 5,037 957 -
Sales, General and Admin. 27,806 28,318 12,071 5,581
Non-Recurring Items 38,115 - - -
Other 6,037 4,328 1,020 841
Operating Income (63,593) (29,884) (12,478) (6,575)
Income From Continuing Operations

Add'l Income/Expense Items 12,200 (2,717) - (336)
Earnings Before Interest and Tax (51,456) (32,580) (12,478) (6,912)
Interest Expense - - - -
Earnings Before Tax (51,456) (32,580) (12,478) (6,912)
Income Tax (2,619) (9,977) - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (48,837) (22,603) (12,478) (6,912)
Non Recurring Events

Discontinued Operations - - - (1,466)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (48,837) (22,603) (12,478) (8,378)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (48,837) (22,603) (12,478) (8,378)

HIPP Hipcricket, Inc. Research DD Guide

HIPP Hipcricket, Inc. Stock Message Board http://investorshangout.com/search?q=HIPP&...mp;yt0=Go!
HIPP Hipcricket, Inc. Stock Quote http://www.otcmarkets.com/stock/HIPP/quote
HIPP Hipcricket, Inc. Stock Chart http://www.otcmarkets.com/stock/HIPP/chart
HIPP Hipcricket, Inc. Company Info http://www.otcmarkets.com/stock/HIPP/company-info
HIPP Hipcricket, Inc. Recent News http://www.otcmarkets.com/stock/HIPP/news
HIPP Hipcricket, Inc. Financials http://www.otcmarkets.com/stock/HIPP/financials
HIPP Hipcricket, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/HIPP/filings
HIPP Hipcricket, Inc. Short Sales http://www.otcmarkets.com/stock/HIPP/short-sales
HIPP Hipcricket, Inc. Insider Disclosure http://www.otcmarkets.com/stock/HIPP/insider-transactions
HIPP Hipcricket, Inc. Research Reports http://www.otcmarkets.com/stock/HIPP/research
HIPP Hipcricket, Inc. Summary http://finance.yahoo.com/q?s=HIPP
HIPP Hipcricket, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=HIPP+Historical+Prices
HIPP Hipcricket, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=HIPP
HIPP Hipcricket, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=HIPP+Basic+Chart
HIPP Hipcricket, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=HIPP+Basic+Tech.+Analysis
HIPP Hipcricket, Inc. Headlines http://finance.yahoo.com/q/h?s=HIPP+Headlines
HIPP Hipcricket, Inc. Press Releases http://finance.yahoo.com/q/p?s=HIPP+Press+Releases
HIPP Hipcricket, Inc. Company Profile http://finance.yahoo.com/q/pr?s=HIPP+Profile
HIPP Hipcricket, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=HIPP+Key+Statistics
HIPP Hipcricket, Inc. Industry http://finance.yahoo.com/q/in?s=HIPP+Industry
HIPP Hipcricket, Inc. Major Holders http://finance.yahoo.com/q/mh?s=HIPP+Major+Holders
HIPP Hipcricket, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=HIPP+Insider+Transactions
HIPP Hipcricket, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=HIPP+Insider+Roster
HIPP Hipcricket, Inc. Income Statement http://finance.yahoo.com/q/is?s=HIPP
HIPP Hipcricket, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=HIPP
HIPP Hipcricket, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=HIPP+Cash+Flow&annual
HIPP Hipcricket, Inc. Nasdaq http://www.nasdaq.com/symbol/HIPP
HIPP Hipcricket, Inc. Market Watch http://www.marketwatch.com/investing/stock/HIPP
HIPP Hipcricket, Inc. Bloomberg http://www.bloomberg.com/quote/HIPP:US
HIPP Hipcricket, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=HIPP
HIPP Hipcricket, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=HIPP
HIPP Hipcricket, Inc. Barchart http://www.barchart.com/quotes/stocks/HIPP
HIPP Hipcricket, Inc. OTC Short Report http://otcshortreport.com/index.php?index=HIPP
HIPP Hipcricket, Inc. Investopedia http://www.investopedia.com/markets/stocks/HIPP/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading